Top news of the week: 11.08.2020.

#coronavirus #biospace #biotechnology #vaccine #COVID19 #COVID #treatment #lifesciences #pharmaceuticals #pandemic

Companies And Industries

On Aug 10, 2020
@Biotechnology shared
Biopharma Update on the Novel Coronavirus: August 10 https://t.co/T87WK36fnY https://t.co/ymxrvw8KPX
Open

Biopharma Update on the Novel Coronavirus: August 10

Biopharma Update on the Novel Coronavirus: August 10

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 10, 2020.

On Aug 5, 2020
@biospace shared
Biopharma Update on the Novel Coronavirus: August 5 #biospace #lifesciences #biotechnology #pharmaceuticals #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine https://t.co/H4l2EBmBAj
Open

Biopharma Update on the Novel Coronavirus: August 5

Biopharma Update on the Novel Coronavirus: August 5

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 5, 2020.

On Aug 9, 2020
@IAmBiotech shared
#Biopharma Update on the Novel #Coronavirus: August 7 https://t.co/kyrY7hfBl1 https://t.co/Ng3IlzjHhp
Open

Biopharma Update on the Novel Coronavirus: August 7

Biopharma Update on the Novel Coronavirus: August 7

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 7, 2020.

On Aug 10, 2020
@BiotechWorld shared
PPD squeezes out a revenue growth despite COVID-19 disruption https://t.co/LwQFLULVOP https://t.co/cazTy0f8Dp
Open

PPD squeezes out a revenue growth despite COVID-19 disruption

PPD squeezes out a revenue growth despite COVID-19 disruption

Contract Research Organization PPD has seen its revenue nudge up in the second quarter as it navigates trial disruption while helping run one of the world’s most closely watched vaccine ...

On Aug 6, 2020
@GENbio shared
GEN Edge -- A #Unicorn Rivalry Shaping the Future of the #Synbio Industry. Read More on the Key Players: https://t.co/HWo8CrH3d4 https://t.co/0P20rqWxoc
Open

A Unicorn Rivalry Shaping the Future of the Synbio Industry

A Unicorn Rivalry Shaping the Future of the Synbio Industry

Two companies have embraced the power of computational biology to take the guesswork out of synthetic biology and drive the industry into the mainstream.

On Aug 6, 2020
@chelsbells4 shared
RT @BKenney1: Legend, in collaboration with Janssen, will continue to advance this investigational therapy in China and globally. https://t.co/Pk9swax0sX
Open
On Aug 7, 2020
@chelsbells4 shared
RT @DrMichelleBIO: When I started at @IAmBiotech 2 months ago…I said we would tackle big issues. This is one. Today we’re announcing the BIOEquality Agenda. It consists of 3 pillars of change: 1. Promote 2. Invest 3. Expand Learn more ⬇️ https://t.co/glKPiPWi46
Open

BIOEquality Agenda

BIOEquality Agenda

The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.

On Aug 5, 2020
@FierceBiotech shared
“You can see there was no difference between the responses in 5 and 25 mcg. In other words, this is a dose sparing regimen,” Novavax R&D chief Gregory Glenn, M.D., said https://t.co/D7SWrrOh7R
Open

Novavax’s COVID-19 vaccine looks promising in early data

Novavax’s COVID-19 vaccine looks promising in early data

A month after scoring $1.6 billion from the U.S. government, Novavax is posting the first human data from its COVID-19 vaccine. The early data, from the phase 1 part of a phase 1/2 study, ...